Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Sepkovic

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 29, 1999
Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year periodD S Michaud, J E Manson, D Spiegelman, et al.
Cancer Detection and Prevention|May 25, 1999
Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer riskE Taioli, H L Bradlow, S V Garbers, et al.
Environmental Health Perspectives|November 1, 1991
Approaches for assessing health risks from complex mixtures in indoor air: a panel overviewC J Henry, L Fishbein, W J Meggs, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2000
A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acidR T Falk, S C Rossi, T R Fears, et al.
Steroids|August 1, 1996
Urinary markers of estrogen metabolism 2- and 16 alpha-hydroxylation in premenopausal womenA Pasagian-Macaulay, E N Meilahn, H L Bradlow, et al.
Epidemiology (Cambridge, Mass.)|October 31, 2000
Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal womenP Muti, H L Bradlow, A Micheli, et al.
Gynecologic Oncology|August 6, 2000
Placebo-controlled trial of indole-3-carbinol in the treatment of CINM C Bell, P Crowley-Nowick, H L Bradlow, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 29, 1999
Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year periodD S Michaud, J E Manson, D Spiegelman, et al.
Cancer Detection and Prevention|May 25, 1999
Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer riskE Taioli, H L Bradlow, S V Garbers, et al.
Environmental Health Perspectives|November 1, 1991
Approaches for assessing health risks from complex mixtures in indoor air: a panel overviewC J Henry, L Fishbein, W J Meggs, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2000
A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acidR T Falk, S C Rossi, T R Fears, et al.
Steroids|August 1, 1996
Urinary markers of estrogen metabolism 2- and 16 alpha-hydroxylation in premenopausal womenA Pasagian-Macaulay, E N Meilahn, H L Bradlow, et al.
Epidemiology (Cambridge, Mass.)|October 31, 2000
Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal womenP Muti, H L Bradlow, A Micheli, et al.
Gynecologic Oncology|August 6, 2000
Placebo-controlled trial of indole-3-carbinol in the treatment of CINM C Bell, P Crowley-Nowick, H L Bradlow, et al.
Pageof 5